New Horizons – Innovative Approaches To Prolong Survival: Case Studies
Innovative Approaches to Prolong Survival: Case Studies presented by Dr. Ciara Kelly of Memorial Sloan Kettering Cancer Center at New Horizons 2019 in Wayne, NJ.
Innovative Approaches to Prolong Survival: Case Studies presented by Dr. Ciara Kelly of Memorial Sloan Kettering Cancer Center at New Horizons 2019 in Wayne, NJ.
The following is a recap of the presentations and posters from the CTOS conference held in Hawaii, with commentary by David Josephy. Dr. Michael Heinrich, David Josephy and Norman Scherzer CTOS 2017 Presentations Related [...]
At its heart, the Life Raft Group is a love story. In this video, Norman Scherzer shares two love stories, and asks us all to continue to keep the spirit of love alive [...]
The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared [...]
Jason Sicklick, M.D Recent findings from a population-based retrospective cohort study at the at Moores Cancer Center at UC San Diego Health, led by senior author, Jason Sicklick, M.D., indicate that small [...]
MaKayla Evens help kick off our holiday campaign. MaKayla Evans was diagnosed with Wild Type GIST in 2011, when she was 14 years old. She wanted to speak knowledgeably with her doctors [...]
#GivingTuesday, November 29th, is a day dedicated to being generous. In direct contrast to #BlackFriday and #CyberMonday, days that are set aside for consumerism, it is an opportunity for coming together as a community [...]
Loxo Oncology announced in a press release that the FDA has granted breakthrough therapy designation to LOXO-101 for the treatment of unresectable or metastatic solid tumors with neurotrophic tyrosine receptor kinase gene fusions. This [...]
The 14th Pediatric and Wildtype GIST Clinic was held at the National Institute of Health (NIH) in Bethesda, Maryland on June 15-17, 2016. What follows is a summary of the discussion held during the [...]
We are in the midst of one of the most exciting times in history to be involved in cancer research. Over 60 anti-cancer drugs have gained FDA-approval in the last 10 years, and that [...]